comparemela.com

Latest Breaking News On - Aisling capital - Page 4 : comparemela.com

SEC's Recent Rule Changes For Private Fund Advisers: What You Need To Know - Securities

On August 23, 2023, the Securities and Exchange Commission (the "SEC") enacted new rules and amendments (the "Final Rules") under the Investment Advisers Act of 1940, as amended (the "Advisers Act").

Davidg-tahan
Andrewh-jacobus
Omar-zaki
Peterb-van-raalte
Zvi-rhine
Aisling-capital
Matter-of-corinthian-capital-group
Exchange-commission
Matter-of-aisling-capital
Capital-group
Matter-of-finser-international-corporation
Investment-advisers-act

COMPASS Pathways Secures $285 Million Towards Psychedelics for Mental Health

COMPASS Pathways Secures $285 Million Towards Psychedelics for Mental Health
hightimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hightimes.com Daily Mail and Mail on Sunday newspapers.

Alexandria
Al-iskandariyah
Egypt
Cambridge
Cambridgeshire
United-kingdom
United-states
New-york
Houston
Texas
London
City-of

COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors

 Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to an additional $160 million tied to exercise of warrants Net proceeds. -Today at 08:59 am- MarketScreener

London
City-of
United-kingdom
United-states
Christopher-williams
Stephen-schultz
Kabir-nath
Nasdaq-stock-market
Nasdaq
Morgan-stanley
Linkedin
Drug-administration

COMPASS Pathways plc (CMPS) Announces $285M Private Placement at $7.78/sh

COMPASS Pathways plc (CMPS) Announces $285M Private Placement at $7.78/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
United-kingdom
Stephen-schultz
Kabir-nath
Christopher-williams
Drug-administration
Exchange-commission
Health-sciences
Nasdaq-stock-market
Nasdaq
Morgan-stanley
Linkedin

Up To $285M In Financing: COMPASS Pathways' Private Placement Backed By 'Select Group' Of Investors - Compass Pathways (NASDAQ:CMPS)

Psychedelics biotech giant COMPASS Pathways (NASDAQ: CMPS) has entered into a securities purchase agreement for an initial $125 million and potential additional of $160 million, with a select group of healthcare specialist investors. 

United-states
American
Kabir-nath
Morgan-stanley
Aisling-capital
Depositary-shares
Securities-act
Treatment-resistant-depression

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.